Anxiety disorders are the most prevalent psychiatric disorders and a leading cause of
disability. While there continues to be expansive research in posttraumatic stress disorder …

After application, antidepressants, like other pharmaceuticals, are excreted from human
body in their native form or as metabolites and enter the aquatic environment via different …

This revision of the 2005 British Association for Psychopharmacology guidelines for the
evidence-based pharmacological treatment of anxiety disorders provides an update on key …

Introduction Selective serotonin reuptake inhibitors (SSRIs) and, to a lesser extent, serotonin‐
norepinephrine reuptake inhibitors (SNRIs) are the cornerstone of pharmacotherapy for …

Epigenetic signatures such as methylation of the monoamine oxidase A (MAOA) gene have
been found to be altered in panic disorder (PD). Hypothesizing temporal plasticity of …

The neuromodulatory arousal system imbues the nervous system with the flexibility and
robustness required to facilitate adaptive behaviour. While there are well understood …

Objective: Concurrent anxiety and/or insomnia symptoms in women with postpartum
depression (PPD) are common and associated with more severe PPD. The effects of …

Introduction: Behavioural and psychological symptoms of dementia (BPSD) include agitation
and aggression in people with dementia. BPSD is common on inpatient psychogeriatric …

Despite the well-established role of serotonin signaling in mood regulation, causal
relationships between serotonergic neuronal activity and behavior remain poorly …

Objective To review the symptoms of serotonin toxicity (commonly referred to as serotonin
syndrome) and the causative drugs and their mechanisms of action, and to equip primary …